Clinical trials
Recruiting Phase 1/2 Myelodysplastic Syndromes trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 9 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 5 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 29 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 5 |
| Advanced BioDesign | 1 |
| AstraZeneca | 1 |
| BeOne Medicines | 1 |
| Chordia Therapeutics, Inc. | 1 |
| Ciusss de L'Est de l'Île de Montréal | 1 |
| Disc Medicine, Inc | 1 |
| Ellipses Pharma | 1 |
| Fred Hutchinson Cancer Center | 1 |
| Groupe Francophone des Myelodysplasies | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 29 |
| Leukemia, Myeloid, Acute | 18 |
| Leukemia, Myelomonocytic, Chronic | 5 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 |
| Myeloproliferative Disorders | 3 |
| Anemia, Aplastic | 2 |
| Anemia, Refractory, with Excess of Blasts | 2 |
| Hodgkin Disease | 2 |
| Leukemia, Biphenotypic, Acute | 2 |
| Lymphoma, Non-Hodgkin | 2 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.